Table 2 Distribution and prevalence of DRMs among HIV-1 subtypes in PLWHA with detectable viremia after ART.

From: HIV-1 subtype distribution and drug resistance profiles among PLWHA with detectable viremia in Henan Province, China, 2023

Subtype

Total

     

Patients

 

DR

 

χ2

p

n

%

n

%

B

450

55.97%

307

68.22%

20.416

0.002

CRF01_AE

178

22.14%

133

74.72%

CRF07_BC

124

15.42%

65

52.42%

CRF55_01B

27

3.36%

22

81.48%

CRF08_BC

8

1.00%

5

62.50%

C

5

0.62%

4

80.00%

Others

12

1.49%

9

75.00%

Total

804

100.00%

545

67.79%

  1. Univariate logistic regression analysis was performed. CRF, circulating recombinant forms; DR, drug.Others, other subtypes, including CRF67_01B, CRF62_BC, CRF02_AG, CRF03_A6B, CRF52_01B, CRF59_01B, CRF68_01B and G.
Back to article page